These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30755792)

  • 21. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Higa Y; Nakanishi S; Sogawa Y; Nomura K; Nishimura H; Hoshino J; Sawa N; Katori H; Takemoto F; Nakamura M; Tomikawa S; Hara S; Takaichi K
    Nephron Clin Pract; 2009; 112(3):c157-63. PubMed ID: 19390216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budd-Chiari syndrome in autosomal dominant polycystic kidney disease: a complication of nephrectomy in patients with liver cysts.
    Clive DM; Davidoff A; Schweizer RT
    Am J Kidney Dis; 1993 Feb; 21(2):202-5. PubMed ID: 8430682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
    Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
    Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.
    Luciano RL; Dahl NK
    Nephrol Dial Transplant; 2014 Feb; 29(2):247-54. PubMed ID: 24215018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F; Williams O; Chapman A
    Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal Dominant Polycystic Kidney Disease.
    Perumareddi P; Trelka DP
    Prim Care; 2020 Dec; 47(4):673-689. PubMed ID: 33121636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal dominant polycystic kidney disease.
    Srivastava A; Patel N
    Am Fam Physician; 2014 Sep; 90(5):303-7. PubMed ID: 25251090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current recommendations for treating autosomal dominant polycystic kidney disease.
    Ness B; Stovall K
    JAAPA; 2016 Dec; 29(12):24-28. PubMed ID: 27811548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal dominant polycystic kidney disease - clinical and genetic aspects.
    Bogdanova N; Markoff A; Horst J
    Kidney Blood Press Res; 2002; 25(5):265-83. PubMed ID: 12435872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form.
    Nicolau C; Torra R; Badenas C; Pérez L; Oliver JA; Darnell A; Brú C
    Nephrol Dial Transplant; 2000 Sep; 15(9):1373-8. PubMed ID: 10978393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic Kidney/Liver Disease.
    Roediger R; Dieterich D; Chanumolu P; Deshpande P
    Clin Liver Dis; 2022 May; 26(2):229-243. PubMed ID: 35487607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
    Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
    Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
    Noël N; Rieu P
    Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of autosomal dominant polycystic kidney disease.
    Bennett WM; Elzinga LW
    Kidney Int Suppl; 1993 Jul; 42():S74-9. PubMed ID: 8361135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.
    Park HC; Kim CW; Ro H; Moon JY; Oh KH; Kim Y; Lee JS; Yin YH; Jae HJ; Chung JW; Ahn C; Hwang YH
    J Korean Med Sci; 2009 Feb; 24(1):57-61. PubMed ID: 19270814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial cysts in autosomal dominant polycystic kidney disease.
    Schievink WI; Huston J; Torres VE; Marsh WR
    J Neurosurg; 1995 Dec; 83(6):1004-7. PubMed ID: 7490613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal recessive and dominant polycystic kidney diseases.
    Sessa A; Righetti M; Battini G
    Minerva Urol Nefrol; 2004 Dec; 56(4):329-38. PubMed ID: 15785425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.